Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mallikarjuna Rao Pichika

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Drug Discovery Today|November 26, 2018
Artificial intelligence in drug development: present status and future prospectsKit-Kay Mak, Mallikarjuna Rao Pichika
Drug Discovery Today|November 14, 2021
The role of DMPK science in improving pharmaceutical research and development efficiencyKit-Kay Mak, Ola Epemolu, Mallikarjuna Rao Pichika
Pharmacognosy Research|August 3, 2011
Antiproliferative activity and induction of apoptosis in estrogen receptor-positive and negative human breast carcinoma cell lines by Gmelina asiatica rootsMadhu Katyayani Balijepalli, Satyanarayana Tandra, Mallikarjuna Rao Pichika
Oncotargets and Therapy|November 16, 2013
Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancersChun Wai Mai, Yew Beng Kang, Mallikarjuna Rao Pichika
Acta Crystallographica. Section E, Structure Reports Online|September 19, 2013
2-Meth-oxy-4-(prop-2-en-1-yl)phenyl 2,4-di-chloro-benzoateMallikarjuna Rao Pichika, Yew Beng Kang, Seik Weng Ng
Expert Opinion on Drug Discovery|September 23, 2021
Success stories of AI in drug discovery - where do things stand?Kit-Kay Mak, Madhu Katyayani Balijepalli, Mallikarjuna Rao Pichika
Journal of Biomolecular Structure & Dynamics|August 13, 2015
An in silico approach towards the identification of novel inhibitors of the TLR-4 signaling pathwayJarjapu Mahita, K Harini, Mallikarjuna Rao Pichika, et al.
Acta Crystallographica. Section E, Structure Reports Online|June 25, 2013
2-Meth-oxy-4-(prop-2-en-1-yl)phenyl 4-meth-oxy-benzoateMallikarjuna Rao Pichika, Beng Kang Yew, Seik Weng Ng
Acta Crystallographica. Section E, Structure Reports Online|September 19, 2013
2-Meth-oxy-4-(prop-2-en-1-yl)phenyl benzoateMallikarjuna Rao Pichika, Yew Beng Kang, Seik Weng Ng
Pharmacognosy Magazine|October 9, 2010
Antimicrobial activity of Bauhinia tomentosa and Bauhinia vahlii rootsSwarnalatha Dugasani, Madhu Katyayani Balijepalli, Satyanarayana Tandra, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Drug Discovery Today|November 26, 2018
Artificial intelligence in drug development: present status and future prospectsKit-Kay Mak, Mallikarjuna Rao Pichika
Drug Discovery Today|November 14, 2021
The role of DMPK science in improving pharmaceutical research and development efficiencyKit-Kay Mak, Ola Epemolu, Mallikarjuna Rao Pichika
Pharmacognosy Research|August 3, 2011
Antiproliferative activity and induction of apoptosis in estrogen receptor-positive and negative human breast carcinoma cell lines by Gmelina asiatica rootsMadhu Katyayani Balijepalli, Satyanarayana Tandra, Mallikarjuna Rao Pichika
Oncotargets and Therapy|November 16, 2013
Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancersChun Wai Mai, Yew Beng Kang, Mallikarjuna Rao Pichika
Acta Crystallographica. Section E, Structure Reports Online|September 19, 2013
2-Meth-oxy-4-(prop-2-en-1-yl)phenyl 2,4-di-chloro-benzoateMallikarjuna Rao Pichika, Yew Beng Kang, Seik Weng Ng
Expert Opinion on Drug Discovery|September 23, 2021
Success stories of AI in drug discovery - where do things stand?Kit-Kay Mak, Madhu Katyayani Balijepalli, Mallikarjuna Rao Pichika
Journal of Biomolecular Structure & Dynamics|August 13, 2015
An in silico approach towards the identification of novel inhibitors of the TLR-4 signaling pathwayJarjapu Mahita, K Harini, Mallikarjuna Rao Pichika, et al.
Acta Crystallographica. Section E, Structure Reports Online|June 25, 2013
2-Meth-oxy-4-(prop-2-en-1-yl)phenyl 4-meth-oxy-benzoateMallikarjuna Rao Pichika, Beng Kang Yew, Seik Weng Ng
Acta Crystallographica. Section E, Structure Reports Online|September 19, 2013
2-Meth-oxy-4-(prop-2-en-1-yl)phenyl benzoateMallikarjuna Rao Pichika, Yew Beng Kang, Seik Weng Ng
Pharmacognosy Magazine|October 9, 2010
Antimicrobial activity of Bauhinia tomentosa and Bauhinia vahlii rootsSwarnalatha Dugasani, Madhu Katyayani Balijepalli, Satyanarayana Tandra, et al.
Pageof 6